Hypercholesterolemia impairs immunity to tuberculosis

Infection and Immunity

Volumn 76, Issue 8, 2008, Pages 3464-3472

  Martens, Gregory W ^a   Arikan, Meltem Cevik ^a   Lee, Jinhee ^a   Ren, Fucheng ^a   Vallerskog, Therese ^a   Kornfeld, Hardy ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GAMMA INTERFERON; APOLIPOPROTEIN E; CYTOKINE;

ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CELL INFILTRATION; CELL LINE; CELL PROLIFERATION; CELL STRAIN OT II; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE PRODUCTION; EX VIVO STUDY; HISTOPATHOLOGY; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNITY; LIPID DIET; LOW FAT DIET; MORTALITY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; TUBERCULOSIS; WILD TYPE; ANIMAL; BACTERIAL COUNT; C57BL MOUSE; DISEASE PREDISPOSITION; GRANULOCYTE; HUMAN; IMMUNOLOGY; LUNG; LUNG ABSCESS; MICROBIOLOGY; MONONUCLEAR CELL; MOUSE MUTANT; PATHOLOGY; SPLEEN; SURVIVAL;

ANIMALS; APOLIPOPROTEINS E; COLONY COUNT, MICROBIAL; CYTOKINES; DISEASE SUSCEPTIBILITY; GRANULOCYTES; HUMANS; HYPERCHOLESTEROLEMIA; LEUKOCYTES, MONONUCLEAR; LUNG; LUNG ABSCESS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; SURVIVAL ANALYSIS; TUBERCULOSIS;

EID: 48849098369     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00037-08     Document Type: Article

References (35)

1. Alieke, G. V., N. de Bont, M. G. Netea, P. N. Demacker, J. W. van der Meer, A. F. Stalenhoef, and B. J. Kullberg. 2004. Apolipoprotein-E-deficient mice exhibit an increased susceptibility to disseminated candidiasis. Med. Mycol. 42:341-348.
2. Angeli, V., J. Llodra, J. X. Rong, K. Satoh, S. Ishii, T. Shimizu, E. A. Fisher, and G. J. Randolph. 2004. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21:561-574.
3. Barnden, M. J., J. Allison, W. R. Heath, and F. R. Carbone. 1998. Defective TCR expression in transgenic mice constructed using cDNA-based alpha-and beta-chain genes under the control of heterologous regulatory elements. Immunol. Cell Biol. 76:34-40.
4. Bjorkbacka, H., V. V. Kunjathoor, K. J. Moore, S. Koehn, C. M. Ordija, M. A. Lee, T. Means, K. Halmen, A. D. Luster, D. T. Golenbock, and M. W. Freeman. 2004. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10:416-421.
5. de Bont, N., M. G. Netea, P. N. Demacker, B. J. Kullberg, J. W. van der Meer, and A. F. Stalenhoef. 2000. Apolipoprotein E-deficient mice have an impaired immune response to Klebsiella pneumoniae. Eur. J. Clin. Investig. 30:818-822.
6. Flynn, J. L., and J. Chan. 2001. Immunology of tuberculosis. Annu. Rev. Immunol. 19:93-129.
7. Grainger, D. J., J. Reckless, and E. McKilligin. 2004. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J. Immunol. 173:6366-6375.
8. Imperatore, G., B. L. Cadwell, L. Geiss, J. B. Saadinne, D. E. Williams, E. S. Ford, T. J. Thompson, K. M. Narayan, and E. W. Gregg. 2004. Thirty-year trends in cardiovascular risk factor levels among US adults with diabetes: National Health and Nutrition Examination Surveys, 1971-2000. Am. J. Epidemiol. 160:531-539.
9. Jung, Y. J., R. LaCourse, L. Ryan, and R. J. North. 2002. Virulent but not avirulent Mycobacterium tuberculosis can evade the growth inhibitory action of a T helper 1-dependent, nitric oxide synthase 2-independent defense in mice. J. Exp. Med. 196:991-998.
10. Lammas, D. A., E. De Heer, J. D. Edgar, V. Novelli, A. Ben-Smith, R. Barette, P. Drysdale, J. Binch, C. MacLennan, D. S. Kumararatne, S. Panchalingam, T. H. Ottenhoff, J. L. Casanova, and J. F. Emile. 2002. Heterogeneity in the granulomatous response to mycobacterial infection in patients with defined genetic mutations in the interleukin 12-dependent interferon-gamma production pathway. Int. J. Exp. Pathol. 83:1-20.
11. Ludewig, B., M. Jaggi, T. Dumrese, K. Brduscha-Riem, B. Odermatt, H. Hengartner, and R. M. Zinkernagel. 2001. Hypercholesterolemia exacerbates virus-induced immunopathologic liver disease via suppression of anti-viral cytotoxic T cell responses. J. Immunol. 166:3369-3376.
12. MacMicking, J. D., R. J. North, R. LaCourse, J. S. Mudgett, S. K. Shah, and C. F. Nathan. 1997. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. USA 94:5243-5248.
13. Martens, G. W., M. C. Arikan, J. Lee, F., Ren, D. Greiner, and H. Kornfeld. 2007. Tuberculosis susceptibility of diabetic mice. Am. J. Respir. Cell Mol. Biol. 37:518-524.
14. Mogues, T., M. E. Goodrich, L. Ryan, R. LaCourse, and R. J. North. 2001. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J. Exp. Med. 193:271-280.
15. National Center for Health Statistics. 2006. Technical notes. Health, United States, 2006 with chartbook on trends in the health of Americans, p. 106-435. U.S. Government Printing Office, Hyattsville, MD.
16. Oda, N., P. B. Canelos, D. M. Essayan, B. A. Plunkett, A. C. Myers, and S. K. Huang. 2005. Interleukin-17F induces pulmonary neutrophilia and amplifies antigen-induced allergic response. Am. J. Respir. Crit. Care Med. 171:12-18.
17. Orme, I. M. 2001. Immunology and vaccinology of tuberculosis: can lessons from the mouse be applied to the cow? Tuberculosis 81:109-113.
18. Ottenhoff, T. H., D. Kumararatne, and J. L. Casanova. 1998. Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol. Today 19:491-494.
19. Pearl, J. E., B. Saunders, S. Ehlers, I. M. Orme, and A. M. Cooper. 2001. Inflammation and lymphocyte activation during mycobacterial infection in the interferon-gamma-deficient mouse. Cell Immunol. 211:43-50.
20. Pedrosa, J., B. M. Saunders, R. Appelberg, I. M. Orme, M. T. Silva, and A. M. Cooper. 2000. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect. Immun. 68:577-583.
21. Perez, A., H. S. Brown III, and B. I. Restrepo. 2006. Association between tuberculosis and diabetes in the Mexican border and non-border regions of Texas. Am. J. Trop. Med. Hyg. 74:604-611.
22. Perez-Guzman, C., M. H. Vargas, F. Quinonez, N. Bazavilvazo, and A. Aguilar. 2005. A cholesterol-rich diet accelerates bacteriologic sterilization in pulmonary tuberculosis. Chest 127:643-651.
23. Piedrahita, J. A., S. H. Zhang, J. R. Hagaman, P. M. Oliver, and N. Maeda. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA 89:4471-4475.
24. Robertson, A. K., X. Zhou, B. Strandvik, and G. K. Hansson. 2004. Severe hypercholesterolaemia leads to strong Th2 responses to an exogenous antigen. Scand. J. Immunol. 59:285-293.
25. Roselaar, S. E., and A. Daugherty. 1998. Apolipoprotein E-deficient mice have impaired innate immune responses to Listeria monocytogenes in vivo. J. Lipid Res. 39:1740-1743.
26. Sassetti, C. M., D. H. Boyd, and E. J. Rubin. 2003. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 48:77-84.
27. Scanga, C. A., V. P. Mohan, K. Tanaka, D. Alland, J. L. Flynn, and J. Chan. 2001. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobacterium tuberculosis in mice. Infect. Immun. 69:7711-7717.
28. Seiler, P., P. Aichele, B. Raupach, B. Odermatt, U. Steinhoff, and S. H. Kaufmann. 2000. Rapid neutrophil response controls fast-replicating intracellular bacteria but not slow-replicating Mycobacterium tuberculosis. J. Infect. Dis. 181:671-680.
29. Shamshiev, A. T., F. Ampenberger, B. Ernst, L. Rohrer, B. J. Marsland, and M. Kopf. 2007. Dyslipidemia inhibits Toll-like receptor-induced activation of CD8α-negative dendritic cells and protective Th1 type immunity. J. Exp. Med. 204:441-452.
30. Tabas, I. 2002. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Investig. 10:905-911.
31. + T cell response to Mycobacterium tuberculosis and exacerbates the outcome of infection. J. Immunol. 175:3268-3272.
32. Van der Geize, R., K. Yam, T. Heuser, M. H. Wilbrink, H. Hara, M. C. Anderton, E. Sim, L. Dijkhuizen, J. E. Davies, W. W. Mohn, and L. D. Eltis. 2007. A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc. Natl. Acad. Sci. USA 104:1947-1952.
33. World Health Organization. 2002. Quantifying selected major risks to health. World health report 2002: reducing risks, promoting healthy life, p. 49-97. World Health Organization, Geneva, Switzerland.
34. World Health Organization. 2007. Global tuberculosis control: surveillance, planning, financing. WHO report 2007, p. 1-270. World Health Organization, Geneva, Switzerland.
35. Zhou, X., G. Paulsson, S. Stemme, and G. K. Hansson. 1998. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J. Clin. Investig. 101:1717-1725.